Trial · NCT07896135
Effects of Hop-Stabilization Training on Postural and Functional Rehabilitation in Children With Lower-Limb Burns
NCT07896135, Not applicable, Completed, Qassim University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Hop-Stabilization Training on Postural and Functional Rehabilitation in Children With Lower-Limb Burns. Trials, record NCT07896135. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896135
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Hop-Stabilization Training on Postural and Functional Rehabilitation in Children With Lower-Limb Burns
- NCT number
- NCT07896135
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 54 participants, actual
- Lead sponsor
- Qassim University
- Conditions
- Burn Injury, Postural Balance Disorders, Gait Impairment
- Interventions
- Progressive Hop-Stabilization Training, Traditional physical therapy
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postural Stability | Baseline (Pre-Intervention) | Postural stability and dynamic Limits of Stability (LOS) were assessed using the ProKin System. Across three maximum-effort trials with 60-second rest intervals, the software calculated: Mediolateral Excursion Limit (%), Anteroposterior Excursion Limit (%), Overall Excursion Area (mm2), Directional Control Index, and Trunk Displacement Angle (o), with the mean of three successful trials retained for statistical analysis. |
| Primary | Postural Stability | Week 8 (Post-Intervention) | Postural stability and dynamic Limits of Stability (LOS) were assessed using the ProKin System. Across three maximum-effort trials with 60-second rest intervals, the software calculated: Mediolateral Excursion Limit (%), Anteroposterior Excursion Limit (%), Overall Excursion Area (mm2), Directional Control Index, and Trunk Displacement Angle (o), with the mean of three successful trials retained for statistical analysis. |
| Primary | Lower Quarter Y-Balance Test (YBT-LQ) | Baseline (Pre-Intervention) | Dynamic balance was assessed using the Lower Quarter Y-Balance Test (YBT-LQ). Participants stood on one leg on the central platform and reached as far as possible with the contralateral leg in the anterior (AT), posteromedial (PM), and posterolateral (PL) directions while maintaining balance. The composite score for was calculated as: composite score (%) = \[AT + PM + PL maximal reach distances (cm)\] / \[3 × lower-limb length (cm)\] × 100. |
| Primary | Lower Quarter Y-Balance Test (YBT-LQ) | Week 8 (Post-Intervention) | Dynamic balance was assessed using the Lower Quarter Y-Balance Test (YBT-LQ). Participants stood on one leg on the central platform and reached as far as possible with the contralateral leg in the anterior (AT), posteromedial (PM), and posterolateral (PL) directions while maintaining balance. The composite score for was calculated as: composite score (%) = \[AT + PM + PL maximal reach distances (cm)\] / \[3 × lower-limb length (cm)\] × 100. |
| Secondary | Functional Gait Assessment Modified for Children | Baseline (Pre-Intervention) | Functional gait performance was assessed using the Functional Gait Assessment modified for Children (FGA-mC). The FGA-mC consists of 10-item assessment designed to evaluate higher-level gait performance under progressively challenging conditions. Higher scores indicate better functional gait performance. |
| Secondary | Functional Gait Assessment Modified for Children | Week 8 (Post-Intervention) | Functional gait performance was assessed using the Functional Gait Assessment modified for Children (FGA-mC). The FGA-mC consists of 10-item assessment designed to evaluate higher-level gait performance under progressively challenging conditions. Higher scores indicate better functional gait performance. |
| Secondary | Single Hop for Distance Test | Baseline (Pre-Intervention) | The Single Hop for Distance Test used to assess unilateral lower-limb functional performance, including forward propulsion and landing control. Hop distance was measured to the nearest 0.5 cm from the starting line to the posterior aspect of the heel at landing. To allow standardized comparisons, absolute hop distance (cm) was normalized to leg length and demonstrated as a percentage. |
| Secondary | Single Hop for Distance Test | Week 8 (Post-Intervention) | The Single Hop for Distance Test used to assess unilateral lower-limb functional performance, including forward propulsion and landing control. Hop distance was measured to the nearest 0.5 cm from the starting line to the posterior aspect of the heel at landing. To allow standardized comparisons, absolute hop distance (cm) was normalized to leg length and demonstrated as a percentage. |
| Secondary | Timed Up and Down Stairs Test | Baseline (Pre-Intervention) | Timed Up and Down Stairs Test was used to assess functional mobility. the subject was asked to stand 30 cm from the bottom of a 14-step flight of stairs (19.5-cm step height). The test score was the time in seconds from the "go" cue until the second foot returned to the bottom land |
| Secondary | Timed Up and Down Stairs Test | Week 8 (Post-Intervention) | Timed Up and Down Stairs Test was used to assess functional mobility. the subject was asked to stand 30 cm from the bottom of a 14-step flight of stairs (19.5-cm step height). The test score was the time in seconds from the "go" cue until the second foot returned to the bottom land |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896135
GET https://conductscience.org/api/trials/v1/NCT07896135/registered